Navigation Links
Congressional Briefing on Civic Engagement
Date:11/19/2008

You are invited to attend a congressional breakfast briefing on the subject of civic engagement on Tuesday, November 25, 2008. This event will serve as the closing session of the 61st Annual Scientific Meeting of The Gerontological Society of America (GSA).

President-Elect Barack Obama has voiced support for an expanded federal commitment to volunteer service, so civic engagement advocates are preparing to work quickly with congressional leaders to enact service legislation early in the 111th Congress. The speakers include policy makers, civic engagement experts, corporate leaders, advocates, and volunteers who will share their visions for a more perfect environment for service.

Representatives from the Health, Education, Labor, and Pensions Committee and Senator Orrin Hatch's (R-UT) office and others will discuss proposed national service bills, including the Serve America Act (S. 3487) and the Encore Service Act (S. 3480). Also participating will be former U.S. Senator Harris Wofford, AARP COO Tom Nelson, and IBM VP of Corporate Citizenship and Corporate Affairs Stanley Litow.


'/>"/>

Contact: Todd Kluss
tkluss@geron.org
202-587-2839
The Gerontological Society of America
Source:Eurekalert

0

GOOD

Page: 1

Related medicine news :

1. After Financial Bailout, a Long Term Care Bailout? No, Industry Expert Says, Pointing to Recent Congressional Action
2. Nations Leading Healthcare Providers, Unions to Share Solutions With Congressional Leaders for Healthcare Crisis
3. Updated MD-CARE Act Receives Final Congressional Approval
4. Lilly to Sponsor Congressional Black Caucus Foundations Annual Legislative Conference
5. PSEG Supports Quick Congressional Action on Clean Air in Wake of Courts Rescinding of CAIR
6. APHA Applauds Congressional Override of Medicare Veto
7. American Life League Applauds Congressional Action Against Planned Parenthood
8. Proposed Congressional Legislation Would Cut $358 Million From the Medicare Advantage Program in Texas
9. Proposed Congressional Legislation Would Cut $143 Million from the Medicare Advantage Program in Georgia
10. Proposed Congressional Legislation Would Cut $222 Million from the Medicare Advantage Program in Massachusetts
11. Proposed Congressional Legislation Would Cut $6.6 Million from the Medicare Advantage Program in New Hampshire
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2009)...hope that finding will lead to treatments, , ...esearchers say they,ve found a major cellular flaw...cancer. , When caught early, lung cancer can of...til the disease is well advanced. Though doctors c...sease often springs back more virulent than ever, ...
(Date:7/3/2009)...ly 3 /PRNewswire-Asia/ -- Sundia MediTech, a leadi...outsourcing company in Shanghai,China announced ... Vice,President of Chemistry Services. , P...ine Biosciences, a drug,discovery and development...aff,scientist to Senior Director of Medicinal Che...
(Date:7/3/2009)... Two companies and three individuals have bee...nnual international competition designed to reward...0-member SafetyXChange.org community released its ... at http://www.safetyxchange.org/saxcies-video . ...ns who dedicate their lives to keeping others safe...
(Date:7/3/2009)... Julian Whitaker, MD, a founder of the altern... searchjointpain.com, a new informational Web site...ions and solutions. , Pot...MD, a founder of the alternative health movement, ... new informational Web site devoted to all aspects...
Breaking Medicine News(10 mins):Health News:Cell Pathway May Be Key to Lung Cancer's Spread 2Health News:Cell Pathway May Be Key to Lung Cancer's Spread 3Health News:Sundia MediTech Appoints Dr. Chen Chen as Senior VP of Chemistry 2Health News:Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 2Health News:Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 3Health News:Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 4Health News:Dr. Julian Whitaker Featured on Searchjointpain.com 2
..., nonsurgical treatment for a benign bone tumor ca... eliminates debilitating pain. The study showed th... with no post-procedure complications. This nonsur... and destroys the nerve endings in the tumor that ...
... some people can eat excessive amounts of food and... others// are more likely to develop obesity and t...study, which used two strains of mice with differi... on a high-fat diet, identified genetic and cellul...
...ontain oxidants that when inhaled can cause damage...sthma// and chronic obstructive pulmonary disease ...chool of Public Health, Boston, identify a new mec...ainst inhaled oxidants. Lester Kobzik and colleag...
...ostate cancer result -- an abnormal screening test...cancer -- appear more likely to worry about their ... with sexual function compared to men with normal ...ersity of Iowa study. The study findings, based o...
Other Medicine News:Health News:Outpatient Treatment Kills Benign Bone Tumors Nonsurgically With Heat 2Health News:Outpatient Treatment Kills Benign Bone Tumors Nonsurgically With Heat 3Health News:Study Finds Fat Type That can Protect Against Weight Gain and Diabetes 2Health News:Study Finds Fat Type That can Protect Against Weight Gain and Diabetes 3Health News:Reactions to 'false-positive' Prostate Cancer Screenings Assessed 2
(Date:7/1/2009)...mark, July 1 A just publ...n Investigational Drugs", Volume,18, Issue 7 2009...PROSTVAC(TM). This is the most comprehensive and u...ote from the article: "Preliminary clinical trials... trials have suggested a survival benefit,after t...
(Date:6/30/2009)... Calixa Therapeutics Inc. today ann...of CXA-101 in patients with complicated urinary tr...parenteral cephalosporin antibiotic with excellent...monas aeruginosa , including drug resistant isolat...l treatment for serious bacterial infections in ho...
(Date:6/29/2009)... for Novel Biotherapeutics Based On Naturally Rese...PRNewswire/ -- Pangu BioPharma, a subsidiary of aT... of its third patent application on proprietary, n...s. Although tRNA synthetases are universal and es...found in all organisms, human synthetases have nat...
(Date:6/26/2009)...ne 26, and OSAKA, Japan, June 27, 2009 /PRNewswire...a") today announced that Takeda Global Research &a...d States (U.S.) subsidiary received on June 26 (U....Food and Drug Administration (FDA) regarding the C..., a selective dipeptidyl peptidase IV (DPP-4) inhi...
Breaking Medicine Technology:New Review on PROSTVAC(TM) Published by Key Investigators From NCI 2Calixa Therapeutics Announces Initiation of Phase 2 Clinical Trial of Its Antibiotic, CXA-101, in Patients with Complicated Urinary Tract Infections 2Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications 2Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications 3Takeda Receives FDA Complete Response Letter for Alogliptin, an Investigational Treatment for Type 2 Diabetes 2Family Halloween Safety Can Be Fiendishly Simple 28388 1Family Halloween Safety Can Be Fiendishly Simple 28388 2SilverScript Insurance Company a CVS Caremark Company Provides Variety of Medicare Prescription Drug Plan Options for 2009 28383 1SilverScript Insurance Company a CVS Caremark Company Provides Variety of Medicare Prescription Drug Plan Options for 2009 28383 2SilverScript Insurance Company a CVS Caremark Company Provides Variety of Medicare Prescription Drug Plan Options for 2009 28383 3Intercim Announces Australia Based Memko to Resell its Pertinence Suite Powered by Velocity in Asia Pacific 28378 1Intercim Announces Australia Based Memko to Resell its Pertinence Suite Powered by Velocity in Asia Pacific 28378 2HMS Holdings Corp Announces Q3 2008 Results 2008 Revised Guidance and Initial 2009 Guidance 28373 1HMS Holdings Corp Announces Q3 2008 Results 2008 Revised Guidance and Initial 2009 Guidance 28373 2HMS Holdings Corp Announces Q3 2008 Results 2008 Revised Guidance and Initial 2009 Guidance 28373 3HMS Holdings Corp Announces Q3 2008 Results 2008 Revised Guidance and Initial 2009 Guidance 28373 4HMS Holdings Corp Announces Q3 2008 Results 2008 Revised Guidance and Initial 2009 Guidance 28373 5HMS Holdings Corp Announces Q3 2008 Results 2008 Revised Guidance and Initial 2009 Guidance 28373 6HMS Holdings Corp Announces Q3 2008 Results 2008 Revised Guidance and Initial 2009 Guidance 28373 7HMS Holdings Corp Announces Q3 2008 Results 2008 Revised Guidance and Initial 2009 Guidance 28373 8HMS Holdings Corp Announces Q3 2008 Results 2008 Revised Guidance and Initial 2009 Guidance 28373 9HMS Holdings Corp Announces Q3 2008 Results 2008 Revised Guidance and Initial 2009 Guidance 28373 10
...1, 2007 /PRNewswire-FirstCall/ --,deCODE genetics ...,Phase I multiple dose clinical trial of DG051, wh...f heart attack. In the study, a,randomized, double...olled clinical trial, a total of 40 healthy subjec...day for seven days.,Building upon the positive res...
...hed Statistical Significance, FRAZER, Pa., May 0...c. Phase 3 clinical trial presented today at the 5...urology in Boston highlights,data demonstrating ...is beneficial for the treatment of breakthrough pa...eady taking opioids around-the,clock to manage t...
Other Medicine Technology:deCODE Announces Positive Topline Results for Phase I Study of,DG051 for the Prevention of Heart Attack 2deCODE Announces Positive Topline Results for Phase I Study of,DG051 for the Prevention of Heart Attack 3Cephalon Presents Positive Results for Fentora in Breakthrough Pain,Associated with Neuropathic Conditions 2Cephalon Presents Positive Results for Fentora in Breakthrough Pain,Associated with Neuropathic Conditions 3Cephalon Presents Positive Results for Fentora in Breakthrough Pain,Associated with Neuropathic Conditions 4Cephalon Presents Positive Results for Fentora in Breakthrough Pain,Associated with Neuropathic Conditions 5Cephalon Presents Positive Results for Fentora in Breakthrough Pain,Associated with Neuropathic Conditions 6Cephalon Presents Positive Results for Fentora in Breakthrough Pain,Associated with Neuropathic Conditions 7
FM Series Oxygen Pediatric Flowmeters, ,Options: , For security chain, add suffix S to model number. Example: FM107S. , For Canadian Color-Code, add suffix C to model number. Example: FM104C. , For
FM Series Oxygen Flowmeters with Power Take Off, ,Options: , For security chain, add suffix S to model number. Example: FM107S. , For Canadian Color-Code, add suffix C to model number. Example: FM10
...signed specifically for detection of recent-onset ...on (AMD). ,This macular perimeter maps and quant...gression of intermediate ("dry") AMD to the wet st...ity to compensate for small visual field defects, ...
...eatures for the professional ophthalmic photograph...camera, slit and background illumination, all cont...ide the slit lamp joystick, as well as adaptors al...ofessional level digital and 35 mm cameras, ensure...
Medicine Products: